- Home
- NURO vs FBIOP Comparison
NURO vs FBIOP Comparison
Compare NURO & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- FBIOP
- Stock Information
- Founded
- NURO 1996
- FBIOP N/A
- Country
- NURO United States
- FBIOP United States
- Employees
- NURO N/A
- FBIOP 101
- Industry
- NURO Medical/Dental Instruments
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- NURO Health Care
- FBIOP Health Care
- Exchange
- NURO Nasdaq
- FBIOP Nasdaq
- Market Cap
- NURO N/A
- FBIOP N/A
- IPO Year
- NURO N/A
- FBIOP N/A
- Fundamental
- Price
- NURO $4.38
- FBIOP $6.45
- Analyst Decision
- NURO
- FBIOP
- Analyst Count
- NURO 0
- FBIOP 0
- Target Price
- NURO N/A
- FBIOP N/A
- AVG Volume (30 Days)
- NURO 2.7K
- FBIOP N/A
- Earning Date
- NURO 05-14-2025
- FBIOP N/A
- Dividend Yield
- NURO N/A
- FBIOP N/A
- EPS Growth
- NURO N/A
- FBIOP N/A
- EPS
- NURO N/A
- FBIOP N/A
- Revenue
- NURO $3,032,837.00
- FBIOP N/A
- Revenue This Year
- NURO N/A
- FBIOP N/A
- Revenue Next Year
- NURO N/A
- FBIOP N/A
- P/E Ratio
- NURO N/A
- FBIOP N/A
- Revenue Growth
- NURO N/A
- FBIOP N/A
- 52 Week Low
- NURO $2.66
- FBIOP N/A
- 52 Week High
- NURO $4.73
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- NURO 48.82
- FBIOP 62.78
- Support Level
- NURO $4.28
- FBIOP $6.00
- Resistance Level
- NURO $4.38
- FBIOP $6.80
- Average True Range (ATR)
- NURO 0.06
- FBIOP 0.38
- MACD
- NURO -0.01
- FBIOP 0.14
- Stochastic Oscillator
- NURO 60.53
- FBIOP 81.73
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.